Phrenic Nerve Stimulation for Reducing Ventilation Duration in Acute Cerebral Infarction: A Multicenter Randomized Controlled Trial

A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 590 participants.

Also called NCT07133932

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; triple masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 590 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT07133932
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Not yet recruiting (from the registry)

Technical summary

Registry record NCT07133932. Randomized; triple masking; primary purpose treatment. Start 2025-09-01 (anticipated); primary completion 2027-12-31 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Phrenic Nerve Stimulation for Reducing Ventilation Duration in Acute Cerebral Infarction: A Multicenter Randomized Controlled Trial
Acronym
EDP-VENT
Condition
Cerebral Infarction
Condition
Mechanical Ventilation
Condition
Acute Cerebrovascular Accident
Condition
Adult
Intervention (Device)
Transcutaneous electrical phrenic nerve stimulation
Intervention (Device)
Sham (No Treatment)
Lead sponsor
Xuanwu Hospital, Beijing (class: other)

Record details

Record id
cardio:ct-nct07133932
Content hash
0487be2f9e4d704a2270cd34b27a585f0e64dc5494e0a2706efeef9e81f0c089